biotechNew
Schrodinger
Physics-based computational platform for drug discovery.
weight 0.0PaidLaunched 2026-06-07
💸 No earnings reported yet
What it is
A computational chemistry company whose physics-based simulation platform sits upstream of pure machine learning, with a near-term shot at an FDA approval via its compound zasocitinib.
How AI plugs in
Physics-based molecular simulation fused with machine learning predicts how candidate molecules bind before synthesis, narrowing the search space upstream of any wet-lab work.
★ Reviews
No reviews yet — be the first.Your rating